| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 2.0 | 4.3 | 5.8 |
| Other income | 0.2 | 0.1 | 0.5 |
| Total income | 2.2 | 4.4 | 6.2 |
| Profit before exceptional items & tax | -0.4 | 0.0 | 1.3 |
| Profit before tax | -0.4 | 0.0 | 1.3 |
| Net profit | 0.6 | 0.0 | 1.3 |
| Operating margin | -18.2% | 0.0% | 21.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -53.80% |
|---|---|
| Revenue, year on year | -65.50% |
Source
Read the filing ↗
BSE results filing, NSE: BRAWN. Figures extracted from the filing.
Brawn Biotech Ltd: key numbers
- Share price
- ₹21.49
- Market cap
- ₹6.45 Cr
- Revenue (annual)
- ₹16.98 Cr
- Net profit (annual)
- ₹0.94 Cr
- P/E (TTM)
- 7.5×Sector 50.4×
- Promoter holding
- 52.94%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Brawn Biotech Ltd
All →
16:46 IST
BSE
Other Announcement
Brawn Biotech Other Announcement
Brawn Biotech informed the exchange that it has issued letters to shareholders regarding the 41st AGM notice and annual report access.
13:09 IST
BSE
Financial Results
Brawn Biotech Q1 FY27 Results: Net Profit ₹0.2 Cr, Up 0.0% YoY
Brawn Biotech Ltd reported revenue from operations of ₹6.1 Cr (+5.2% YoY) and net profit of ₹0.2 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.2 Cr · +0.0% YoY